Loading...
XASX
SIG
Market cap21bUSD
Jul 11, Last price  
2.86AUD
1D
0.35%
1Q
-4.67%
Jan 2017
121.71%
IPO
-22.40%
Name

Sigma Healthcare Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
6.71
EPS
—
Div Yield, %
0.35%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
8.57%
Revenues
4.89b
+47.32%
2,194,552,0002,734,722,0002,994,119,0003,108,467,0003,261,166,0002,939,374,0002,878,233,0002,968,007,0002,973,466,0003,142,126,0003,461,104,0004,366,208,0004,094,440,0003,976,774,0003,244,264,0003,400,379,0003,446,164,0003,660,240,0003,322,058,0004,893,936,000
Net income
-14m
L
104,848,000101,788,00077,154,00080,124,000-389,042,000-235,382,00049,172,00018,686,00053,536,00052,773,00050,502,00053,184,00055,059,00036,520,000-12,330,00043,529,000-7,239,0001,811,0004,509,000-13,842,000
CFO
-316m
L
20,905,00034,552,00036,894,00000101,242,000145,771,00065,626,00079,647,00061,314,00032,151,000145,769,00071,181,0008,470,000200,625,000-13,125,000-46,280,000142,738,00041,965,000-315,591,000
Dividend
Oct 01, 20240.005 AUD/sh
Earnings
Sep 23, 2025

Profile

Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics. In addition, it offers contract logistics services to pharmaceutical manufacturers and other supplier partners. Sigma Healthcare Limited was founded in 1912 and is headquartered in Rowville, Australia.
URL
https://sigmahealthcare.com.au/
IPO date
Oct 30, 2002
Employees
156
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑012024‑012023‑012022‑012021‑012020‑012019‑012018‑012017‑012016‑01
Income
Revenues
4,893,936
47.32%
3,322,058
-9.24%
3,660,240
6.21%
Cost of revenue
4,872,733
3,394,006
3,729,163
Unusual Expense (Income)
NOPBT
21,203
(71,948)
(68,923)
NOPBT Margin
0.43%
Operating Taxes
24,064
3,313
2,435
Tax Rate
113.49%
NOPAT
(2,861)
(75,261)
(71,358)
Net income
(13,842)
-406.99%
4,509
148.98%
1,811
-125.02%
Dividends
(17,132)
(9,981)
(14,960)
Dividend yield
0.38%
0.91%
2.29%
Proceeds from repurchase of equity
2,682
396,117
879
BB yield
-0.06%
-36.17%
-0.13%
Debt
Debt current
10,640
9,789
12,944
Long-term debt
253,532
263,473
348,082
Deferred revenue
134,041
Other long-term liabilities
4,876
33,400
4,909
Net debt
241,074
(104,523)
326,993
Cash flow
Cash from operating activities
(315,591)
41,965
142,738
CAPEX
(7,910)
(4,718)
(29,399)
Cash from investing activities
(1,599)
5,734
(28,604)
Cash from financing activities
(24,730)
295,825
(116,941)
FCF
(297,701)
(27,442)
(8,239)
Balance
Cash
14,574
356,496
16,650
Long term investments
8,524
21,289
17,383
Excess cash
211,682
Stockholders' equity
839,278
872,611
529,448
Invested Capital
976,240
804,739
709,660
ROIC
ROCE
2.17%
EV
Common stock shares outstanding
1,571,640
1,063,315
1,028,057
Price
2.87
178.64%
1.03
62.20%
0.64
41.11%
Market cap
4,510,607
311.85%
1,095,214
67.77%
652,816
-7.63%
EV
4,753,099
992,532
981,657
EBITDA
21,203
(43,625)
(38,587)
EV/EBITDA
224.17
Interest
18,514
16,303
14,407
Interest/NOPBT
87.32%